SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Gelman Sciences Inc – ‘10-K’ for 7/31/96 – EX-11

As of:  Thursday, 10/17/96   ·   For:  7/31/96   ·   Accession #:  950124-96-4405   ·   File #:  1-07828

Previous ‘10-K’:  ‘10-K/A’ on 8/6/96 for 7/31/95   ·   Latest ‘10-K’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/17/96  Gelman Sciences Inc               10-K        7/31/96   19:249K                                   Bowne - Bde

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                         44    248K 
 2: EX-3.(II)   Bylaws                                                15     56K 
 4: EX-10.18    Employment Agreement                                   3     14K 
 5: EX-10.20    Employment Agreement                                   2     11K 
 6: EX-10.21    Waiver and Release                                     1     10K 
 7: EX-10.22    Service Agreement                                      7     17K 
 8: EX-10.23    Letter Agreement                                       1      9K 
 9: EX-10.24    Letter Agreement                                       1     11K 
10: EX-10.25    Promissory Note                                        2     14K 
11: EX-10.26    Amendment to Promissory Note                           2     13K 
12: EX-10.27    Non-Employee Director Stock Plan                       4     19K 
13: EX-10.28    Executive Stock Plan                                   4     20K 
14: EX-10.29    Employment Agreement                                   7     25K 
15: EX-10.30    Stock Option Agreement                                 2     15K 
16: EX-10.31    Stock Option Agreement                                 2     15K 
 3: EX-10.8     Amendment to Consent Judgement                        13     33K 
17: EX-11       Computation of Earnings                                1     10K 
18: EX-21       Subsidiaries                                           1      8K 
19: EX-27       Financial Data Schedule                                1     11K 


EX-11   —   Computation of Earnings

EX-11TOCTopPreviousNextBottomJust 1st
 

[Enlarge/Download Table] Exhibit 11 COMPUTATION OF EARNINGS PER COMMON SHARE PRIMARY AND FULLY DILUTED ---------------------------------------------------------------------------------------------------------------------------- 1996 1995 1994 ---------- ---------- ---------- Net income for computing primary and fully diluted earnings per common share $4,336,000 $6,622,000 $4,754,000 PRIMARY SHARES Weighted average number of common shares outstanding 7,885,206 6,828,809 5,787,236 Additions from assumed exercise of stock options and warrants 369,787 406,464 520,652 ---------- ---------- ---------- Weighted average of common and common equivalent shares 8,254,993 7,235,273 6,307,888 ========== ========= ========= FULLY DILUTED SHARES Weighted average number of common shares outstanding 7,885,206 6,828,809 5,787,236 Additions from assumed exercise of stock options and warrants 403,490 420,925 548,640 ---------- ---------- ---------- Weighted average of common and common equivalent shares 8,288,696 7,249,734 6,335,876 ========== ========= ========= NET INCOME PER COMMON SHARE Primary $ 0.53 $ 0.92 $ 0.75 ========== ========= ========= Fully diluted $ 0.53 $ 0.92 $ 0.75 ========== ========= ========= Primary additions from assumed exercise of stock options and warrants are net of assumed purchase of common shares at the average market price during the fiscal year. Fully diluted earnings per share was determined in the same manner except that the year-end stock price was used. The average and year-end stock prices were as follows: fiscal 1996 - $23.25 and $28.25, fiscal 1995 - $15.53 and $19.875, fiscal 1994 - $10.07 and $13.50, respectively. 29
Top
Filing Submission 0000950124-96-004405   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 5:16:03.1am ET